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Myotonic dystrophy type 1 (DM1) is a slowly progressive neuromuscular disease. The 
overall aim of this thesis was primarily to describe the characteristics, prevalence, and 
development of orofacial functions in a group of children and adolescents with DM1 
and secondly to investigate the effect of lip strengthening exercises. In total, the study 
population consisted of 66 individuals with DM1, five with Möbius syndrome, six 
with facioscapulohumeral muscular dystrophy and 106 healthy controls. Fifty-six of 
the patients (30 males, 26 females; median age 13 years [2–21 years]) with DM1 and 
56 of the healthy age and gender matched controls were enrolled in Study I. Thirty-
five patients and 31 controls were assessed twice with approximately 3–4-year 
intervals (Study II). Facial expression, intelligibility, oral motor performance, and lip 
force, were assessed by a speech-language pathologist and the families answered 
questions about eating and saliva control in a questionnaire. Eight individuals (7–17 
years) from the same study group participated in an intervention study (Study IV). 
After baseline measurements, four participants began 16 weeks of treatment while the 
others acted as controls. Thereafter, those who had started as controls began treatment 
and the other had no training. Lip exercises were carried out five days a week. Follow-
ups were conducted every fourth week. Assessments were performed with both quanti-
tative and qualitative methods. These methods were developed and validated in a pre-
vious methodology study. Lip mobility was measured with 3D video analysis and lip 
strength with a lip force meter. Fifty healthy adults and 23 adults with diagnoses 
affecting the facial muscles participated in the methodology study (Study III). All 
patients with DM1 had impaired facial expression. Intelligibility was considerably 
reduced in 30 patients (60 %), excluding 6 patients without speech. The majority had 
moderate or severe impairment of lip motility (76 %), tongue motility (52 %), and lip 
force (69 %). Deviant production of bilabial and dental consonants was common. 
Families reported problems with drooling (37 %) and eating (52 %). Oral motor dys-
function was most prominent in congenital DM1, and males were more affected than 
females. Intelligibility, eating and drinking ability, and saliva control improved during 
childhood in some patients. Facial expression deteriorated significantly, especially in 
patients with childhood DM1, but the progressive weakening of the orofacial muscles 
also manifested as reduced intelligibility and increased drooling. The measuring 
instruments were found to be reliable as well as clinically relevant and could therefore 
be used for evaluation of treatment as a complement to qualitative assessments.  Seven 
of eight participants in the intervention study improved lip strength but not lip 
function. Orofacial dysfunctions such as impaired facial expression, speech, eating and 
drooling are common in children and adolescents with DM1. Both improved and dete-
riorated orofacial functions could be seen in this group of patients at follow-up. The 
progression of muscle weakness in DM1 is clearly expressed in the deterioration of 
facial expression. Children and adolescents with DM1 can improve lip strength. How-
ever, improved lip strength will not automatically lead to improved lip function. 
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